Immunophenotypic and genotypic characterization of progression in follicular lymphomas

Yasodha Natkunam, Robert Soslow, A. Matolcsy, Milana Dolezal, Vivek Bhargava, Daniel M. Knowles, Roger Warnke

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Progression of follicular lymphomas (FLs) is often accompanied by a spectrum of histologic changes and an aggressive clinical course. Although molecular alterations have been implicated in this event, the underlying factors are largely unknown. We studied the expression of selected tumor suppressor genes (P53 and retinoblastoma [RB]), oncogenes (MYC and BCL2), and a transferrin-receptor related protein (Trump) in sequential biopsies in 16 patients. Eleven patients progressed from grade 1 or 11 FL to aggressive B-cell lymphomas with diffuse morphology, whereas 5 patients presented with diffuse aggressive lymphomas and recurred with indolent lymphomas. Immunoreactivity for P53 correlated with higher histologic grade in lymphomas progressing from indolent to aggressive; however, only 1 patient who presented with aggressive lymphoma demonstrated a P53 gene mutation. Neither P53 immunoreactivity nor genotypic alterations correlated with presentation with an aggressive histology and relapse with FL. Growth fraction, as assessed by Ki-67 staining, and Trump expression correlated with histologic grade. Immunoreactivity for RB, BCL2, and MYC was seldom associated with progression. Eight of 9 cases tested exhibited identical immunoglobulin heavy and light chain rearrangements or identical BCL2 gene rearrangements in the sequential lymphomas. We conclude that P53 and Trump protein expression and proliferation activity correlate with histologic grade, but not with recurrence or progression of FL. Our results further indicate that progression of FL to diffuse aggressive lymphomas and presentation of an aggressive B-cell lymphoma followed by FL are clonally related.

Original languageEnglish
Pages (from-to)97-104
Number of pages8
JournalApplied Immunohistochemistry and Molecular Morphology
Volume12
Issue number2
Publication statusPublished - Jun 2004

Fingerprint

Follicular Lymphoma
Lymphoma
Retinoblastoma
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Immunoglobulin Light Chains
Recurrence
Immunoglobulin Heavy Chains
Transferrin Receptors
Gene Rearrangement
p53 Genes
Tumor Suppressor Genes
Oncogenes
Histology
Proteins
Staining and Labeling
Biopsy
Mutation
Growth

Keywords

  • BCL2
  • Follicular lymphoma
  • Immunohistochemistry
  • MYC
  • P53
  • Progression
  • RB
  • Transferrin receptor
  • Transformation
  • Trump

ASJC Scopus subject areas

  • Anatomy
  • Medical Laboratory Technology

Cite this

Natkunam, Y., Soslow, R., Matolcsy, A., Dolezal, M., Bhargava, V., Knowles, D. M., & Warnke, R. (2004). Immunophenotypic and genotypic characterization of progression in follicular lymphomas. Applied Immunohistochemistry and Molecular Morphology, 12(2), 97-104.

Immunophenotypic and genotypic characterization of progression in follicular lymphomas. / Natkunam, Yasodha; Soslow, Robert; Matolcsy, A.; Dolezal, Milana; Bhargava, Vivek; Knowles, Daniel M.; Warnke, Roger.

In: Applied Immunohistochemistry and Molecular Morphology, Vol. 12, No. 2, 06.2004, p. 97-104.

Research output: Contribution to journalArticle

Natkunam, Y, Soslow, R, Matolcsy, A, Dolezal, M, Bhargava, V, Knowles, DM & Warnke, R 2004, 'Immunophenotypic and genotypic characterization of progression in follicular lymphomas', Applied Immunohistochemistry and Molecular Morphology, vol. 12, no. 2, pp. 97-104.
Natkunam, Yasodha ; Soslow, Robert ; Matolcsy, A. ; Dolezal, Milana ; Bhargava, Vivek ; Knowles, Daniel M. ; Warnke, Roger. / Immunophenotypic and genotypic characterization of progression in follicular lymphomas. In: Applied Immunohistochemistry and Molecular Morphology. 2004 ; Vol. 12, No. 2. pp. 97-104.
@article{e3c6cf5aab994f0989869f6b9fc81357,
title = "Immunophenotypic and genotypic characterization of progression in follicular lymphomas",
abstract = "Progression of follicular lymphomas (FLs) is often accompanied by a spectrum of histologic changes and an aggressive clinical course. Although molecular alterations have been implicated in this event, the underlying factors are largely unknown. We studied the expression of selected tumor suppressor genes (P53 and retinoblastoma [RB]), oncogenes (MYC and BCL2), and a transferrin-receptor related protein (Trump) in sequential biopsies in 16 patients. Eleven patients progressed from grade 1 or 11 FL to aggressive B-cell lymphomas with diffuse morphology, whereas 5 patients presented with diffuse aggressive lymphomas and recurred with indolent lymphomas. Immunoreactivity for P53 correlated with higher histologic grade in lymphomas progressing from indolent to aggressive; however, only 1 patient who presented with aggressive lymphoma demonstrated a P53 gene mutation. Neither P53 immunoreactivity nor genotypic alterations correlated with presentation with an aggressive histology and relapse with FL. Growth fraction, as assessed by Ki-67 staining, and Trump expression correlated with histologic grade. Immunoreactivity for RB, BCL2, and MYC was seldom associated with progression. Eight of 9 cases tested exhibited identical immunoglobulin heavy and light chain rearrangements or identical BCL2 gene rearrangements in the sequential lymphomas. We conclude that P53 and Trump protein expression and proliferation activity correlate with histologic grade, but not with recurrence or progression of FL. Our results further indicate that progression of FL to diffuse aggressive lymphomas and presentation of an aggressive B-cell lymphoma followed by FL are clonally related.",
keywords = "BCL2, Follicular lymphoma, Immunohistochemistry, MYC, P53, Progression, RB, Transferrin receptor, Transformation, Trump",
author = "Yasodha Natkunam and Robert Soslow and A. Matolcsy and Milana Dolezal and Vivek Bhargava and Knowles, {Daniel M.} and Roger Warnke",
year = "2004",
month = "6",
language = "English",
volume = "12",
pages = "97--104",
journal = "Applied Immunohistochemistry and Molecular Morphology",
issn = "1541-2016",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Immunophenotypic and genotypic characterization of progression in follicular lymphomas

AU - Natkunam, Yasodha

AU - Soslow, Robert

AU - Matolcsy, A.

AU - Dolezal, Milana

AU - Bhargava, Vivek

AU - Knowles, Daniel M.

AU - Warnke, Roger

PY - 2004/6

Y1 - 2004/6

N2 - Progression of follicular lymphomas (FLs) is often accompanied by a spectrum of histologic changes and an aggressive clinical course. Although molecular alterations have been implicated in this event, the underlying factors are largely unknown. We studied the expression of selected tumor suppressor genes (P53 and retinoblastoma [RB]), oncogenes (MYC and BCL2), and a transferrin-receptor related protein (Trump) in sequential biopsies in 16 patients. Eleven patients progressed from grade 1 or 11 FL to aggressive B-cell lymphomas with diffuse morphology, whereas 5 patients presented with diffuse aggressive lymphomas and recurred with indolent lymphomas. Immunoreactivity for P53 correlated with higher histologic grade in lymphomas progressing from indolent to aggressive; however, only 1 patient who presented with aggressive lymphoma demonstrated a P53 gene mutation. Neither P53 immunoreactivity nor genotypic alterations correlated with presentation with an aggressive histology and relapse with FL. Growth fraction, as assessed by Ki-67 staining, and Trump expression correlated with histologic grade. Immunoreactivity for RB, BCL2, and MYC was seldom associated with progression. Eight of 9 cases tested exhibited identical immunoglobulin heavy and light chain rearrangements or identical BCL2 gene rearrangements in the sequential lymphomas. We conclude that P53 and Trump protein expression and proliferation activity correlate with histologic grade, but not with recurrence or progression of FL. Our results further indicate that progression of FL to diffuse aggressive lymphomas and presentation of an aggressive B-cell lymphoma followed by FL are clonally related.

AB - Progression of follicular lymphomas (FLs) is often accompanied by a spectrum of histologic changes and an aggressive clinical course. Although molecular alterations have been implicated in this event, the underlying factors are largely unknown. We studied the expression of selected tumor suppressor genes (P53 and retinoblastoma [RB]), oncogenes (MYC and BCL2), and a transferrin-receptor related protein (Trump) in sequential biopsies in 16 patients. Eleven patients progressed from grade 1 or 11 FL to aggressive B-cell lymphomas with diffuse morphology, whereas 5 patients presented with diffuse aggressive lymphomas and recurred with indolent lymphomas. Immunoreactivity for P53 correlated with higher histologic grade in lymphomas progressing from indolent to aggressive; however, only 1 patient who presented with aggressive lymphoma demonstrated a P53 gene mutation. Neither P53 immunoreactivity nor genotypic alterations correlated with presentation with an aggressive histology and relapse with FL. Growth fraction, as assessed by Ki-67 staining, and Trump expression correlated with histologic grade. Immunoreactivity for RB, BCL2, and MYC was seldom associated with progression. Eight of 9 cases tested exhibited identical immunoglobulin heavy and light chain rearrangements or identical BCL2 gene rearrangements in the sequential lymphomas. We conclude that P53 and Trump protein expression and proliferation activity correlate with histologic grade, but not with recurrence or progression of FL. Our results further indicate that progression of FL to diffuse aggressive lymphomas and presentation of an aggressive B-cell lymphoma followed by FL are clonally related.

KW - BCL2

KW - Follicular lymphoma

KW - Immunohistochemistry

KW - MYC

KW - P53

KW - Progression

KW - RB

KW - Transferrin receptor

KW - Transformation

KW - Trump

UR - http://www.scopus.com/inward/record.url?scp=2942746417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942746417&partnerID=8YFLogxK

M3 - Article

C2 - 15354733

AN - SCOPUS:2942746417

VL - 12

SP - 97

EP - 104

JO - Applied Immunohistochemistry and Molecular Morphology

JF - Applied Immunohistochemistry and Molecular Morphology

SN - 1541-2016

IS - 2

ER -